Company: RVRC
Filing Date: 2025-10-03
Form Type: S-1/A
Source: 0001213900-25-096094
Chunk: 61

Company: Revium Rx.
Filing Date: 2025-10-03
Form: S-1/A
Chunk 61
---
 share to existing stockholders and an immediate dilution of approximately
$3.07 per share to new investors purchasing Units in this offering. The following table illustrates this per share dilution:

| Assumed initial public offering price per Unit                                                    |     |   |      |     | $ | 3.20 |
| Historical                                                                                        
 net tangible book value per share as of June 30, 2025                                             |     | $ | 0.06 |     |   |      |
| Increase                                                                                          
 in net tangible book value per share attributable to new investors participating in this offering |     | $ | 0.07 |     |   |      |
| Pro                                                                                               
 forma as adjusted net tangible book value per share after this offering                           |     |   |      |     | $ | 0.13 |
| Dilution                                                                                          
 per share to new investors participating in this offering                                         |     |   |      |     | $ | 3.07 |

The foregoing discussion and table does not take
into account further dilution to investors in this offering that could occur upon the exercise of outstanding options and warrants having
a per share exercise price less than the public offering price per share in this Primary Offering.

<div align='center'>34

MARKET PRICE OF AND DIVIDENDS ON THE COMPANY’S

COMMON EQUITY AND RELATED STOCKHOLDER MATTERS</div>

Market Information

Our Common Stock is quoted on the OTCID tier
of the OTC Market under the symbol “RVRC”. Over-the-counter market quotations reflect inter-dealer prices, without retail
mark-up, mark-down or commissions and may not necessarily represent actual transactions. On October 2, 2025, the closing price of our
Common Stock was $0.52. Trading volume in our Common Stock has often been very limited. As a result, the trading price of our Common
Stock has been subject to significant fluctuations. There can be no assurance that a liquid market will develop in the foreseeable future.

We intend to apply to upgrade our Common Stock
to the OTCQB marketplace of the OTC Markets. Among the standard requirements to be eligible for the OTCQB, we must have a public float
of 10% of the total issued and outstanding shares and at least 50 beneficial shareholders each owning at least 100 shares. The Company
must also be required to file reports with the SEC. After the registration statement of which this prospectus is a part of is declared
effective by the SEC,